• Cisapride (R 51619) in iPSC Cardiotoxicity Screens

  2026-09-13

  Cisapride (R 51619) provides a mechanistically informative challenge compound for linking 5-HT4 receptor signaling with hERG channel inhibition in human cardiac models. This guide translates high-content iPSC-cardiomyocyte screening into practical dosing, imaging, electrophysiology, and troubleshooting workflows for cardiac arrhythmia research.

• Measuring Cancer Drug Response Beyond Viability

  2026-09-12

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent dimensions of anticancer drug response. This framework supports more informative in vitro experiments by combining endpoint interpretation with attention to response magnitude, composition, and timing.

• FGF Signalling and Non-Cell-Autonomous Apoptosis Resistance

  2026-09-12

  The reference study shows that apoptotic stress can make neighboring cells harder to kill: stressed cells release FGF2, which activates MEK–ERK signaling and increases pro-survival BCL-2-family proteins. This finding connects treatment-associated resistance in cancer biology with tissue repair and suggests that apoptosis assays should distinguish cell-intrinsic death from paracrine survival effects.

• CAF–ANGPTL4–IQGAP1 Axis in Prostate Cancer

  2026-09-11

  The reference study identifies a paracrine ANGPTL4–IQGAP1 signaling axis through which cancer-associated fibroblasts enhance mitochondrial biogenesis, oxidative phosphorylation, and chemotherapy resistance in prostate cancer cells. Its combination of secretome proteomics, metabolic profiling, interaction assays, and drug screening nominates QGGP as a candidate strategy for improving docetaxel responsiveness, while also highlighting the importance of rigorous native-protein workflows.

• JZL184 for MAGL and Endocannabinoid Research

  2026-09-11

  JZL184 is a selective monoacylglycerol lipase inhibitor for dissecting 2-arachidonoylglycerol control of synaptic, pain, and affective pathways. This practical guide connects target engagement, neuronal assays, LC-MS/MS, and behavioral endpoints while showing how to interpret findings alongside recent cannabidiol research.

• H 89 2HCl for cAMP/PKA Signaling Assays

  2026-09-10

  H 89 2HCl enables practical interrogation of PKA-dependent phosphorylation, neurite remodeling, and cAMP-responsive signaling in biochemical and cell-based models. This guide combines concentration-aware workflow design with safeguards against vehicle effects and higher-dose inhibition of non-PKA kinases.

• OSMI-1: O-GlcNAc Transferase Inhibitor

  2026-09-10

  OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor that reduces protein O-GlcNAcylation and produces a reported IC50 of 2.7 μM. Its cellular and zebrafish benchmarks support controlled O-GlcNAcylation research while also requiring explicit cytotoxicity and acute-toxicity controls.

• Biotin-XX Tyramide Reagent for Surface Proteomics

  2026-09-09

  Biotin-XX Tyramide Reagent combines HRP-driven signal amplification with membrane-impermeant cell-surface labeling, making it useful for low-abundance targets in tissue imaging and proximity proteomics. Its long polar linker helps distinguish extracellular labeling from intracellular signal, supporting more selective astrocyte–neuron interface studies.

• JSH-23: Mapping NF-κB Control in Macrophages

  2026-09-09

  JSH-23 is an NF-κB inhibitor designed to separate p65-dependent transcription from upstream pathway activation. This article presents a practical, mechanistic framework for using it in macrophage assays, inflammasome studies, and the cisplatin-induced acute kidney injury model.

• Mc-Val-Cit-PABC-PNP ADC Linker Workflow

  2026-09-08

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for research workflows involving lysosomal payload release during antibody-drug conjugate synthesis. It is highly soluble in DMSO but insoluble in water and ethanol, so it should be handled as a freshly prepared research reagent rather than an aqueous, diagnostic, or medical formulation.

• A-1210477 and the Logic of MCL-1 Dependence

  2026-09-07

  MCL-1 inhibition is most informative when treated as a functional test of apoptotic dependence rather than a simple expression-driven strategy. This thought-leadership guide connects the canonical MCL-1–BIM–BAX/BAK axis with experimental design, combination studies, competitive positioning, and the translational limits of A-1210477.

• Puromycin Aminonucleoside: Assay Design Logic

  2026-09-07

  Puromycin aminonucleoside is more than a nephrotoxic injury trigger: it is a tunable perturbation for linking transporter activity, podocyte morphology, proteinuria, and glomerular pathology. This guide adds a decision-centered framework and connects renal assay design with lessons from a mechanistic cancer study.

• Selonsertib: Reframing ASK1 in Metabolic Disease

  2026-09-05

  A translational perspective on how Selonsertib (GS-4997) can help dissect the intersection of ASK1 stress signaling, autophagy dysfunction, inflammation, and fibrosis in metabolic disease research.

• Anemoside B4, CD1d, and NLRP3 in Colitis

  2026-09-04

  This preprint identifies a macrophage-centered mechanism through which Anemoside B4 attenuates DSS-induced colitis, linking CD1d to the AKT-STAT1-PRDX1-NF-κB axis and NLRP3 inflammasome activation. Its combination of pharmacological treatment, cell-type analysis, and genetic depletion provides a useful framework for inflammation research, while the absence of peer review and direct target-binding evidence limits mechanistic certainty.

• Verapamil as a Causal Probe in Urothelial Hypoxia

  2026-09-04

  Verapamil ((±)-Verapamil) can do more than mark a treatment response: it can help separate calcium-linked, oxidative, and inflammasome-associated events in urothelial hypoxia assays. This evidence-led guide converts duration-resolved findings into a rigorous experimental interpretation framework.

8119 records 1/542 page Next 12345 下5页 Last page